Literature DB >> 31344253

Frontline management of nodular lymphocyte predominant Hodgkin lymphoma - a retrospective UK multicentre study.

Matthew R Wilson1, Timothy Bagguley2, Alexandra Smith2, Eve Roman2, Russell Patmore3, Katharine Hanlon1, Mike Leach1, Mark Bishton4, Cathy Burton5, Pam McKay1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31344253     DOI： 10.1111/bjh.16109

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach.

Authors:  Phoebe T M Cheng; Diego Villa; R Petter Tonseth; David W Scott; Alina S Gerrie; Ciara L Freeman; Tom Pickles; Andrea C Lo; Pedro Farinha; Jeffrey W Craig; Graham W Slack; Randy D Gascoyne; François Bénard; Don Wilson; Brian Skinnider; Joseph M Connors; Laurie H Sehn; Kerry J Savage
Journal:  Blood Adv       Date:  2021-09-28

2.  Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle East.

Authors:  Saad Akhtar; M Shahzad Rauf; Yasser Khafaga; Amani Al-Kofide; Tusneem Ahmed M Elhassan; Mahmoud A Elshenawy; Juzer Nadri; Ali Hassan Mushtaq; Nasir Bakshi; Mohammed Shamayel; Suleiman Al-Sweedan; Sohail Sarwar; Irfan Maghfoor
Journal:  BMC Cancer       Date:  2021-04-01       Impact factor: 4.430

3.  Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research Network.

Authors:  Maxine Je Lamb; Eve Roman; Debra A Howell; Eleanor Kane; Timothy Bagguley; Cathy Burton; Russell Patmore; Alexandra G Smith
Journal:  BJGP Open       Date:  2019-12-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.